# Arcus Biosciences, Inc.: filings

RCUS · NYSE · CIK 1724521 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rcus.md) · [Financials](/companies/rcus/financials.md) · [Filings](/companies/rcus/filings.md) · [Insiders](/companies/rcus/insiders.md)

## Reports and events: 146 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 254, 8-K 95, 144 50, 3 30, 10-Q 26, SC 13G/A 21, SC 13G 16, DEFA14A 10, S-8 9, 10-K 8, 424B5 8, DEF 14A 8, CORRESP 7, UPLOAD 6, S-3ASR 5, ARS 4, CT ORDER 3, SC 13D 3, 144/A 2, 8-K/A 2, DRS/A 2, DRSLTR 2, EFFECT 2, S-1/A 2, SCHEDULE 13G/A 2, 424B4 1, 4/A 1, 8-A12B 1, CERT 1, DRS 1, S-1 1, S-1MEF 1, S-3 1, SC 13D/A 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 20:12 ET | [8-K](/filings/0001724521-26-000050.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001724521-26-000050 |
| 2026-10-21 | 20:09 ET | [8-K](/filings/0001193125-26-427829.md) | 2.02 Results of operations | 0001193125-26-427829 |
| 2026-10-20 | 12:33 ET | [8-K](/filings/0001724521-26-000047.md) | 8.01 Other events | 0001724521-26-000047 |
| 2026-08-05 | 20:11 ET | [10-Q](/filings/0001724521-26-000044.md) | Quarterly report, period 2026-06-30 | 0001724521-26-000044 |
| 2026-08-05 | 20:07 ET | [8-K](/filings/0001724521-26-000042.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001724521-26-000042 |
| 2026-06-12 | 20:12 ET | [8-K](/filings/0001724521-26-000037.md) | 5.07 Shareholder vote results | 0001724521-26-000037 |
| 2026-05-05 | 20:11 ET | [10-Q](/filings/0001724521-26-000034.md) | Quarterly report, period 2026-03-31 | 0001724521-26-000034 |
| 2026-05-05 | 20:09 ET | [8-K](/filings/0001724521-26-000032.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001724521-26-000032 |
| 2026-04-21 | 20:06 ET | [DEF 14A](/filings/0001724521-26-000025.md) | Proxy statement, period 2026-06-11 | 0001724521-26-000025 |
| 2026-04-20 | 11:56 ET | [8-K](/filings/0001724521-26-000021.md) | 8.01 Other events | 0001724521-26-000021 |
| 2026-03-23 | 11:46 ET | [8-K](/filings/0001724521-26-000014.md) | 5.02 Departure or appointment of officers or directors | 0001724521-26-000014 |
| 2026-02-25 | 21:11 ET | [10-K](/filings/0001724521-26-000009.md) | Annual report, period 2025-12-31 | 0001724521-26-000009 |
| 2026-02-25 | 21:08 ET | [8-K](/filings/0001724521-26-000007.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001724521-26-000007 |
| 2025-12-18 | 21:05 ET | [8-K](/filings/0001724521-25-000122.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001724521-25-000122 |
| 2025-12-12 | 13:34 ET | [8-K](/filings/0001724521-25-000120.md) | 8.01 Other events | 0001724521-25-000120 |
| 2025-11-03 | 21:17 ET | [8-K](/filings/0001193125-25-262589.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-262589 |
| 2025-10-28 | 20:12 ET | [10-Q](/filings/0001724521-25-000116.md) | Quarterly report, period 2025-09-30 | 0001724521-25-000116 |
| 2025-10-28 | 20:08 ET | [8-K](/filings/0001724521-25-000114.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001724521-25-000114 |
| 2025-10-14 | 13:00 ET | [8-K](/filings/0001724521-25-000109.md) | 8.01 Other events | 0001724521-25-000109 |
| 2025-10-06 | 14:02 ET | [8-K](/filings/0001724521-25-000107.md) | 8.01 Other events | 0001724521-25-000107 |
| 2025-08-06 | 20:13 ET | [10-Q](/filings/0001724521-25-000101.md) | Quarterly report, period 2025-06-30 | 0001724521-25-000101 |
| 2025-08-06 | 20:09 ET | [8-K](/filings/0001724521-25-000099.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001724521-25-000099 |
| 2025-06-12 | 20:21 ET | [8-K](/filings/0001724521-25-000078.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001724521-25-000078 |
| 2025-06-02 | 12:25 ET | [8-K](/filings/0001724521-25-000066.md) | 7.01 Regulation FD disclosure; 8.01 Other events | 0001724521-25-000066 |
| 2025-05-06 | 20:12 ET | [10-Q](/filings/0001724521-25-000063.md) | Quarterly report, period 2025-03-31 | 0001724521-25-000063 |
| 2025-05-06 | 20:09 ET | [8-K](/filings/0001724521-25-000061.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001724521-25-000061 |
| 2025-04-22 | 20:09 ET | [DEF 14A](/filings/0001724521-25-000052.md) | Proxy statement, period 2025-06-10 | 0001724521-25-000052 |
| 2025-02-25 | 21:09 ET | [10-K](/filings/0001724521-25-000040.md) | Annual report, period 2024-12-31 | 0001724521-25-000040 |
| 2025-02-25 | 21:07 ET | [8-K](/filings/0001724521-25-000039.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001724521-25-000039 |
| 2025-02-19 | 21:05 ET | [8-K](/filings/0001193125-25-029591.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-029591 |
| 2025-02-18 | 11:44 ET | [8-K](/filings/0001193125-25-028110.md) | 2.02 Results of operations; 8.01 Other events | 0001193125-25-028110 |
| 2025-02-06 | 22:02 ET | [8-K](/filings/0001724521-25-000024.md) | 5.02 Departure or appointment of officers or directors | 0001724521-25-000024 |
| 2025-01-21 | 21:11 ET | [8-K](/filings/0001724521-25-000005.md) | 5.02 Departure or appointment of officers or directors | 0001724521-25-000005 |
| 2024-12-17 | 02:52 ET | [SC 13D/A](/filings/0001193125-24-280681.md) | Ownership report, active investor, amended | 0001193125-24-280681 |
| 2024-11-06 | 21:25 ET | [10-Q](/filings/0001724521-24-000160.md) | Quarterly report, period 2024-09-30 | 0001724521-24-000160 |
| 2024-11-06 | 21:23 ET | [8-K](/filings/0001724521-24-000159.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001724521-24-000159 |
| 2024-10-24 | 20:11 ET | [8-K](/filings/0001724521-24-000153.md) | 7.01 Regulation FD disclosure; 8.01 Other events | 0001724521-24-000153 |
| 2024-08-27 | 20:12 ET | [8-K](/filings/0001724521-24-000144.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001724521-24-000144 |
| 2024-08-08 | 20:15 ET | [10-Q](/filings/0001724521-24-000138.md) | Quarterly report, period 2024-06-30 | 0001724521-24-000138 |
| 2024-08-08 | 20:09 ET | [8-K](/filings/0001724521-24-000136.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001724521-24-000136 |
| 2024-06-06 | 20:28 ET | [8-K](/filings/0001724521-24-000101.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001724521-24-000101 |
| 2024-06-03 | 12:18 ET | [8-K](/filings/0001724521-24-000099.md) | 7.01 Regulation FD disclosure; 8.01 Other events | 0001724521-24-000099 |
| 2024-05-23 | 20:59 ET | [8-K](/filings/0001724521-24-000096.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001724521-24-000096 |
| 2024-05-08 | 20:08 ET | [10-Q](/filings/0001724521-24-000092.md) | Quarterly report, period 2024-03-31 | 0001724521-24-000092 |
| 2024-05-08 | 20:05 ET | [8-K](/filings/0001724521-24-000090.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001724521-24-000090 |
| 2024-04-23 | 20:08 ET | [DEF 14A](/filings/0001724521-24-000079.md) | Proxy statement, period 2024-06-06 | 0001724521-24-000079 |
| 2024-02-21 | 21:16 ET | [10-K](/filings/0001724521-24-000052.md) | Annual report, period 2023-12-31 | 0001724521-24-000052 |
| 2024-02-21 | 21:08 ET | [8-K](/filings/0001724521-24-000050.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001724521-24-000050 |
| 2024-01-30 | 13:17 ET | [8-K](/filings/0001724521-24-000034.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001724521-24-000034 |
| 2023-11-07 | 21:11 ET | [10-Q](/filings/0001724521-23-000021.md) | Quarterly report, period 2023-09-30 | 0001724521-23-000021 |

Page 1 of 3. [Older](/companies/rcus/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.